Updated:
Philadelphia Health Partnership
Philadelphia Health Partnership was founded in 1997 as a private foundation dedicated to improving health outcomes for underserved communities in the...
Philadelphia Health Partnership
Philadelphia Health Partnership was founded in 1997 as a private foundation dedicated to improving health outcomes for underserved communities in the Philadelphia region. Executive Director Ann Marie Healy oversees the foundation's grant-making and investment strategy, with governance from a board chaired by Peter J. Zuleba III, the President and CEO of Glenmede. Unlike a single-family office rooted in a named fortune, the partnership pools philanthropic capital and deploys it through a dual mandate: direct program support for local health initiatives and a sophisticated, multi-asset investment program designed to grow its endowment. The foundation's investment portfolio spans public fixed income, private equity, venture capital, and real estate. Vanguard Total Bond Fund and Vanguard Short Term Bond Fund holdings provide a liquid fixed-income base, while commitments to vehicles like Crow Real Estate Fund VIIIA, Patron Fund V, and Madison International Realty Fund extend the foundation into commercial and mixed-use properties across Dallas, London, and New York. The strategy covers the full venture lifecycle, from seed and early-stage to late-stage and buyout, with confirmed investment types including fund of funds and hedge funds. Geographic focus remains primarily North American across all asset classes. The foundation's executive director, Ann Marie Healy, co-chairs the Pennsylvania Health Funders Collaborative, and the organization maintains active memberships in Philanthropy Network Greater Philadelphia and the Sunday Breakfast Club. Board member Philip M. Fitzgerald also serves as Chief Impact Officer at Philadelphia Foundation, creating a governance overlap with the broader regional philanthropic infrastructure. The board itself blends investment management and impact expertise: Jordan A. Brown is a principal at healthcare-focused growth equity firm 1315 Capital, and Elizabeth A. Eldridge is President of Glenmede Investment Management. No new fund closes, leadership changes, or major portfolio disclosures have been publicly reported in the last 24 months. Structurally, the partnership operates as a hybrid between a traditional grant-making foundation and a disciplined institutional allocator. The endowment's diversification into alternative assets, combined with the board's deep ties to Philadelphia's financial and philanthropic ecosystems, positions it to pursue both mission-aligned local grants and market-rate returns. The absence of a single-family wealth source means the foundation's capital is replenished by investment performance and fundraising, not a named patriarch's liquidity events — a structural differentiator that influences its long-term allocation pacing and risk appetite.
General information
Firm type
Endowment / Foundation
Year founded
1997
Location
Region
North America
Country
United States
City
Philadelphia
Corporate office
Philadelphia, PA, United States
Principals
Ann Marie Healy
Executive Director
Peter J. Zuleba III
Board Chair
Jordan A. Brown
Board Member
Elizabeth A. Eldridge
Board Member
Philip M. Fitzgerald
Board Member
Sector focus
Frequently asked questions
How does Philadelphia Health Partnership's dual grant-making and investment mandate work?
The foundation combines direct program-related grants to community health organizations with an institutional investment program designed to preserve and grow its endowment. Grant-making focuses on health equity in the Philadelphia region, while the endowment allocates across private equity, venture capital, hedge funds, fixed income, and real estate. Board members with asset management backgrounds — including Glenmede's President and the President of Glenmede Investment Management — provide oversight for the investment strategy.
What investment stages and asset classes does the foundation target?
The foundation invests across the full spectrum — seed, early-stage, late-stage, and buyout — primarily through fund commitments. Confirmed asset classes include private equity, venture capital, real estate, hedge funds, and public fixed income. Specific fund holdings show exposure to commercial real estate in Dallas, mixed-use in London, commercial properties in New York, and Vanguard bond strategies.
Who runs investment decisions at Philadelphia Health Partnership?
Executive Director Ann Marie Healy leads the foundation's overall strategy. The board includes Peter J. Zuleba III, President and CEO of Glenmede, and Elizabeth A. Eldridge, President of Glenmede Investment Management, both of whom bring institutional asset management expertise. Jordan A. Brown, a principal at healthcare growth equity fund 1315 Capital, adds domain-specific investment knowledge.
Is Philadelphia Health Partnership a single-family office?
No. The foundation is a not-for-profit private foundation, not a single-family office. Unlike family offices structured around a named family's wealth, Philadelphia Health Partnership pools philanthropic capital and sustains itself through investment returns and fundraising. Its governance, investment committee, and board structure reflect a charitable foundation rather than a family-controlled entity.
How is Philadelphia Health Partnership connected to the broader Philadelphia philanthropic community?
The foundation is deeply embedded in the regional philanthropic network. Ann Marie Healy co-chairs the Pennsylvania Health Funders Collaborative, and the foundation is an active member of Philanthropy Network Greater Philadelphia and the Sunday Breakfast Club. Board member Philip M. Fitzgerald serves as Chief Impact Officer at Philadelphia Foundation, creating a direct governance link to another major regional funder.
Does Philadelphia Health Partnership participate in direct deals or only fund commitments?
The portfolio consists primarily of fund commitments — the foundation acts as a limited partner in real estate, private equity, and venture capital funds rather than making direct company investments. Its real estate exposure comes through vehicles like Crow Real Estate Fund VIIIA and Patron Fund V, while alternative allocations are sourced through fund-of-funds and hedge fund structures.
What is the foundation's known posture on co-investments alongside external GPs?
There is no public evidence that Philadelphia Health Partnership participates in direct co-investments. The investment types consistently reported — fund of funds, hedge funds, real estate fund commitments, and public fixed income — suggest a preference for intermediated access through external managers rather than building out a direct or co-investment program.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: